Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Our Top Contrarian Play On Inflation (For 7%+ Dividends And Upside)

Published 01/13/2022, 04:25 AM
Updated 04/03/2018, 07:55 AM

These days, everyone’s in a tizzy about rising interest rates. But what if I told you that this panic is overblown—and it’s setting us up for some very nice windows to buy some top-quality high-yield funds throwing off payouts of 7% and up?

Why do I think it’s overblown? We’ll get into that below. But before we do, we should be careful to acknowledge that the early-2022 “crash” pundits are bleating about isn’t much of a crash at all:

You Call This A Crash?

SPY 2022 Price Chart

The SPDR® S&P 500 (NYSE:SPY) is down less than 2%, and while that isn’t great, it isn’t terrifying, either, especially when we zoom out just three months.

…This Definitely Isn’t A Crash

SPY 3m Price Chart

That’s Exhibit A in my case that rising-rate fears are overblown: the press is panicking more than the markets!

The Fed’s Outdated Fears

Here’s Exhibit B: Back in the middle of December, the Federal Reserve released minutes of its monthly meeting, which said, and I quote, “Current conditions included a stronger economic outlook, higher inflation and a larger balance sheet, and thus could warrant a potentially faster pace of policy rate normalization.”

The press ran with this, with headlines pointing to a more hawkish Fed ready to raise rates faster. What wasn’t reported is that the Fed also noted that Omicron might hinder economic activity, a fact that may cause the central bank to hold off on rate hikes, at least for a little while.

What Everyone Gets Wrong About the Inflation Rate

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

That’s not even the main thing about this inflation scare that everyone’s overlooking. Because the truth is, the numbers almost guarantee that it will ease up in the coming months.

Here’s what I mean: inflation really picked up in America in April 2021, after vaccines started rolling out and people tried to get back to some semblance of normalcy.

Inflation Rises In Early ’21…

Inflation Monthly YoY Chart

Of course, these are year-over-year numbers, so the rate of change depends not just on inflation in 2021, but in 2020, as well. And the chart from that pandemic-crushed year is, well, quite different.

…But That’s Mostly Because It Plunged A Year Earlier

2020-Inflation Chart

See how inflation began to drop sharply in March 2020, leveling out only around August? Those low rates of inflation, when compared against 2021, made for alarmingly high numbers last year. But 2022’s figures will be compared to those high rates of growth in 2021, so it naturally follows that this year’s inflation will look tamer as we get into spring. And now, with Omicron spreading, there’s reason to think inflation will look tamer even before that.

The Fed’s Future Timetable

To be sure, the Fed will raise rates this year, but the market is now betting on a fast and sharp increase—and that’s looking less likely with the uncertainty Omicron brings and the easier comparables to 2021, whose effect we’ll soon start to see.

This also means that from now until spring we’re likely to have more market panics—some red days that are going to be great opportunities for us to buy high-yield stock-focused closed-end funds (CEFs) from the portfolio of my CEF Insider service.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Some of the funds we hold have truly massive yields, like the Tekla Life Sciences Investors (NYSE:HQL), which pays 9% as I write this and holds leading pharmaceutical stocks like Moderna (NASDAQ:MRNA), Amgen (NASDAQ:AMGN), and Regeneron Pharmaceuticals (NASDAQ:REGN). That leaves HQL nicely dialed in to the trend toward higher healthcare spending which is pretty much locked in post-COVID-19.

In fact, today’s setup in the markets reminds me a lot of early 2016.

2016 Gives Us An Early Look At What’s Coming

2016 SPY Interest Rate Chart

As short-term interest rates rose (the orange line) after the Fed announced in late 2015 that it would start raising rates (after nearly a decade of keeping rates low), the stock market dipped…a little. Then it recovered and ended 2016 up 12%. Just six years later, it looks like history is repeating itself.

Disclosure: Brett Owens and Michael Foster are contrarian income investors who look for undervalued stocks/funds across the U.S. markets. Click here to learn how to profit from their strategies in the latest report, "7 Great Dividend Growth Stocks for a Secure Retirement."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.